Ezetimibe

Category:Active Pharmaceutical Ingredients > Other Active Pharmaceutical Ingredients
Product Name:Ezetimibe
CAS No.:163222-33-1
Standard:ChP, USP, BP, EP, JP, In-house Standards
Price(USD):0.00
Company:Chemvon Biotechnology Co.,Ltd

Basic Info
  • Grade: Pharmaceutical Grade

    Factory Location: SH

    Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa

  • Monthly Production Capacity: 100KG/DAYS

    Contract Manufacturing: CRO

    Packaging Information: foil bag/bottle

  • Delivery Lead Time: ship immediate if there have stock

    Sample Provided: yes

    Payment Terms: T/T,LC

    Product name:  Ezetimibe

    Purity:  99% min

    Synonym:  1-(4-fluorophenyl)-3-[3-(4-fluorophenyl)-3-hydroxy-propyl]-4-(4-hydroxyphenyl)-azetidin-2-one;EZETIMIBE;ZETIA;Ezitimibe?EzetimibeC24H21F2N03;(3R,4S)-1-(4-Fluorophenyl)-3-[(3S)-3-(4-fluorophenyl)-3-hydroxypropyl]-4-(4-hydroxyphenyl)-2-azetidinone, Sch-58235;1-(4-Flurophenyl)-(3R)-3-(4-flurophenyl)-(3S)-hydroxypropyl-(4S)-(4-hydroxyphenyl)-2-azetidinone;Ezetimide

    CAS NO.: 163222-33-1

    Molecular Formula:  Ezetimibe

     has the molecular formula being C24H21F2NO3

    Molecular weight:Ezetimibe has the molecular weight being 409.43

    Product quality: our professional technicians have studied the characteristic specifications of   Ezetimibe

    (163222-33-1), including appearance, identification, assay, related substances, residual solvents and so on. For more detailed COA, please contact us. Email: marketing@chemvon.com

Send your message to this supplier
  • From:
  • To:
    Chemvon Biotechnology Co.,Ltd
  • Send a Copy to this Email
  • Message:
    Upload Images / Files
    - Supports jpg, jpeg, png,
     gif, pdf, doc, docx,
     xls, xlsx, txt, rar and zip
    - Max upload 3 files;
     Max  total size: 3MB
    (0/3)

    Enter between 20 to 4,000 characters.This is not what you are looking for ? Post a Sourcing Request Now

  • Verification:
PharmaSources Customer Service